# reload+after+2024-01-23 12:44:16.866803
address1§47215 Lakeview Boulevard
city§Fremont
state§CA
zip§94538
country§United States
phone§877 922 9835
website§https://cytekbio.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
fullTimeEmployees§688
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Wenbin  Jiang Ph.D.', 'age': 59, 'title': 'President, CEO & Chairman of the Board', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 964205, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ming  Yan Ph.D.', 'age': 60, 'title': 'CTO & Director', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 616261, 'exercisedValue': 0, 'unexercisedValue': 149671}, {'maxAge': 1, 'name': 'Ms. Valerie T. Barnett J.D.', 'age': 48, 'title': 'General Counsel & Corporate Secretary', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 535983, 'exercisedValue': 0, 'unexercisedValue': 293629}, {'maxAge': 1, 'name': 'Mr. Patrik Sebastian Jeanmonod', 'age': 57, 'title': 'Chief Financial Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 412536, 'exercisedValue': 0, 'unexercisedValue': 2950816}, {'maxAge': 1, 'name': 'Mr. Chris  Williams', 'age': 54, 'title': 'Chief Operating Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Paul D. Goodson', 'title': 'Head of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Allen B. Poirson Ph.D.', 'age': 63, 'title': 'Senior Vice President of Business & Corporate Development', 'yearBorn': 1960, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Philippe  Busque Ph.D.', 'title': 'Senior Vice President of Global Sales & Services', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Connie  Wedel', 'title': 'Chief People Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Melik  Ulusu', 'title': 'Senior Vice President of Operations & Integrated Supply Chain', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§7
compensationRisk§8
shareHolderRightsRisk§8
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.45
priceToSalesTrailing12Months§5.973636
currency§USD
dateShortInterest§1702598400
forwardEps§0.0
exchange§NMS
quoteType§EQUITY
shortName§Cytek Biosciences, Inc.
longName§Cytek Biosciences, Inc.
firstTradeDateEpochUtc§1627047000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a1084d55-a899-3c3b-840b-c763cdf83566
gmtOffSetMilliseconds§-18000000
targetHighPrice§12.0
targetLowPrice§7.0
targetMeanPrice§9.6
targetMedianPrice§9.0
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§5.889
grossMargins§0.57751
ebitdaMargins§-0.11439
trailingPegRatio§None
